Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
0.8288
-0.0025 (-0.30%)
At close: Oct 21, 2026, 4:00 PM EDT
0.8366
+0.0078 (0.94%)
After-hours: Oct 21, 2026, 4:10 PM EDT
Metagenomi Therapeutics Employees
Metagenomi Therapeutics had 113 employees as of June 30, 2026. The number of employees decreased by 58 or 33.92% compared to the same quarter last year. That makes Metagenomi Therapeutics the 30,710th largest employer in the world and 3,919th in the United States.
Employees
113
Change (1Y)
-58
Growth (1Y)
-33.92%
Revenue / Employee
$120,009
Profits / Employee
-$827,097
Market Cap
31.31M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 113 | -58 | -33.92% |
| Mar 31, 2026 | 118 | -58 | -32.95% |
| Dec 31, 2025 | 119 | -83 | -41.09% |
| Sep 30, 2025 | 124 | -83 | -40.10% |
| Jun 30, 2025 | 171 | -57 | -25.00% |
| Mar 31, 2025 | 176 | -61 | -25.74% |
| Dec 31, 2024 | 202 | -34 | -14.41% |
| Sep 30, 2024 | 207 | -16 | -7.17% |
| Jun 30, 2024 | 228 | 28 | 14.00% |
| Mar 31, 2024 | 237 | 37 | 18.50% |
| Dec 31, 2023 | 236 | - | - |
| Sep 30, 2023 | 223 | - | - |
| Jun 30, 2023 | 200 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| EyePoint | 214 |
| Aligos Therapeutics | 82 |
| Evaxion | 46 |
| Filana Therapeutics | 20 |
| BriaCell Therapeutics | 16 |
| CervoMed | 15 |
| TransCode Therapeutics | 12 |
| Impact BioMedical | 2 |
MGX News
- 1 day ago - Metagenomi Therapeutics Transcript: Chardan's 10th Annual Healthcare Conference - Transcripts
- 8 days ago - Metagenomi Therapeutics, Inc. to Participate in the Chardan 10th Annual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Metagenomi Therapeutics Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 7 weeks ago - Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference - GlobeNewsWire
- 1 month ago - Did Metagenomi Therapeutics, Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PRNewsWire
- 2 months ago - Metagenomi price target lowered to $7 from $9 at Wells Fargo - TheFly
- 2 months ago - Metagenomi Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Metagenomi Therapeutics Earnings release: Q2 2026 - Filings